FDA
approval
· 2016-08-09
FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
The FDA approved Camber Pharmaceuticals' supplemental application for IRBESARTAN, a generic irbesartan product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN (IRBESARTAN)